🔎 Trials Near Me

Gara Jalqabaatti › Baayyee Ulfaataa › New York › New York City

Qorannoo klinikaalii Baayyee Ulfaataa New York City, NY keessatti

Qorannoo 19 Baayyee Ulfaataa f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Namoota walitti qabaa jira
  • Weill Cornell -1300 York Avenue, New York
  • Lenox Hill Hospital | Northwell Health, New York
Umuriin 21 hanga 65 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07090005

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Weill Cornell Medicine - Comprehensive Weight Control Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07595549

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Namoota walitti qabaa jiraSadarkaa 2
  • ALSA Research-Manhattan, New York
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Namoota walitti qabaa jiraSadarkaa 3
  • Comprehensive Weight Ctrl Prog, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07720271

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 3
  • New York Gastroenterology Associates, New York
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Namoota walitti qabaa jiraSadarkaa 3
  • Icahn School of Medicine at Mount Sinai, New York
  • New York Gastroenterology Associates, New York
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Namoota walitti qabaa jiraSadarkaa 3
  • NYU Langone Health, New York
  • Weill Cornell Medical College, New York
  • IMA Clinical Research Manhattan, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07392190

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Namoota walitti qabaa jiraSadarkaa 4
  • Equity Medical, New York
  • Care Access - Hoboken, Hoboken · Miili 2 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Kailera Clinical Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901

Alpelisib Challenge Test (ACT)

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
  • Columbia University Irving Medical Center, New York
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07778524

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
  • Mexican Consulate's Ventanilla de Salud (VDS), New York
Umuriin 21 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT05770570

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Namoota walitti qabaa jiraSadarkaa 3
  • Icahn School of Medicine at Mount Sinai, New York
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07575399

Human Models of Selective Insulin Resistance: Alpelisib, Part I

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
  • Columbia University Irving Medical Center, New York
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT06354088

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Namoota walitti qabaa jiraSadarkaa 3
  • NYU Langone Orthopedic Center, New York
  • Hospital For Special Surgery, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07509307

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Dubartoota · Haaromfame 13-Elb-2026 · NCT06751589

CHIME: Comparing Health Interventions for Maternal Equity

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • Columbia University Medical Center, New York
  • NYU Langone Health, New York
Umuriin 18 fi ol · Dubartoota · Haaromfame 05-Bit-2026 · NCT06724172

Effects of Ultra Processed Food on Intestinal Energy Harvest

Namoota walitti qabaa jira
  • Columbia University Irving Medical Center, New York
Umuriin 25 fi ol · Saalaa hunda · Haaromfame 03-Onk-2025 · NCT06853288

Qorannoo Baayyee Ulfaataa magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.